PCN10 COST-EFFCTIVENESS ANALYSIS OF ERLOTINIB COMPARED WITH DOCETAXEL AND PEMETREXED FOR SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN TAIWAN
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65168-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65168-6/fulltext
Title :
PCN10 COST-EFFCTIVENESS ANALYSIS OF ERLOTINIB COMPARED WITH DOCETAXEL AND PEMETREXED FOR SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN TAIWAN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65168-6&doi=10.1016/S1098-3015(10)65168-6
First page :
Section Title :
Open access? :
No
Section Order :
327